PARIS (dpa-AFX) – The French pharmaceutical company Sanofi also wants to help with the production of the corona vaccine from the pharmaceutical company Johnson & Johnson (JohnsonJohnson). As soon as approval for the vaccine has been granted, Sanofi will grant access to its location in Marcy-l’Étoile, the company announced on Monday. Sanofi had already announced that it would grant the Mainz-based company Biontech (BioNTech (ADRs)) access to its production infrastructure in Frankfurt-Höchst and take over late-stage manufacturing steps such as filling to support the delivery of the Covid-19 vaccine.
In Marcy-l’Étoile near Lyon, Sanofi now wants to help with the so-called pharmaceutical formulation and filling of the vaccine from Johnson & Johnson in an order of magnitude of around twelve million doses per month. “Sanofi will take over several production steps for Johnson & Johnson from the third quarter of 2021,” said the company.
The US manufacturer Johnson & Johnson had applied for European approval for its vaccine.
“While our priority remains to advance our two Covid-19 vaccine programs, we recognize that there are opportunities to increase supply and expand access to Covid-19 vaccines,” said Sanofi Director General Paul Hudson. Sanofi also announced the start of a Phase 2 study for its lead vaccine candidate, which is being developed with UK company GSK (GlaxoSmithKline (GlaxoSmithKline)).
“We must work together to accelerate vaccine production through industrial partnerships,” wrote French President Emmanuel Macron on Twitter of Sanofi’s announcement. / Nau / DP / fba